Announcements
ASO webinar: Obesity and Kidney Disease
Professor ALEX MIRAS
#ASOWebinar: Obesity and Kidney Disease Thursday 27th January 2022, 18:00 - 19:30 Obesity is increasingly becoming a common cause for chronic kidney disease, even in the absence of diabetes or…
NICE committee member recruitment - diabetic retinopathy guideline
Dr. Hermione Price
Committee members are being recruited for NICE’s diabetic retinopathy guideline committee. The following roles are being recruited for: consultant ophthalmologist paediatric ophthalmologist…
NCEPOD Transition study - Health and Social Care Professional survey
Dr. Hermione Price
NCEPOD are exploring the process of the transition of young people with complex chronic conditions from child to adult health services. The aim of the study is to explore the barriers and…
Rowan Hillson Inpatient Safety Award 2022
Professor Ketan Dhatariya
Due to the pressure on hospital teams during the COVID pandemic, we postponed the 2021 competition but are now launching a revamped award for 2022 which has been amended to take into account the…
Diabetes & Endocrinology Workforce Census 2022
Dr. Stella George
We have now launched the annual census of Consultants in Diabetes and Endocrinology. This is being done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London…
NCEPOD Transition study - young person and parent carer online survey
Dr. Susannah Rowles
NCEPOD are undertaking a study to look at the process of transition from child to adult health services. As part of this study, they are collecting the views of young people and parent carers…
ABCD publishes the results of the Integrated survey about diabetes services
Dr. Dinesh Nagi
Today, 17th December 2021, ABCD publishes the results of the Integrated survey about diabetes services. https://bjd-abcd.com/index.php/bjd/article/view/781 Please find the link to the raw data of…
Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus
Dr. Hermione Price
As of 25th October 2021, dapagliflozin 5mg is no longer authorised for the treatment of people with type 1 diabetes mellitus (T1DM) and should no longer be used in this population . This is…
The YDEF Marjorie Prize
Dr. Thomas Crabtree
The Young Diabetologist and Endocrinologist Forum committee are very pleased to be able to announce the Marjorie Prize. A little known hero in the discovery of insulin was Marjorie the dog who was…
JBDS enteral feeding forms review - we need your help
Professor Ketan Dhatariya
We are contacting you on behalf of the Joint British Diabetes Societies (JBDS) for inpatient care group. We are currently undertaking a review of our guideline "Glycaemic management during…
Withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes
Dr. Susannah Rowles
ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes . Apologies if you've had this update from multiple sources. We…
JBDS needs your help
Professor Ketan Dhatariya
JBDS is updating the ‘Variable rate intravenous insulin infusion (VRIII) for medical inpatients with diabetes’ guideline and we need your help. We need to collect evidence and are asking UK diabetes…
The DTN committee are aware that questions have arisen since the inclusion of the Medtrum HCL system in the framework, provided by NHS Supply Chain, for the procurement of HCL systems to support the…
